Background: Metabolic syndrome (MetS) is a complex and multifactorial disorder that manifests through a constellation of interconnected metabolic abnormalities. These include central obesity, insulin resistance, dyslipidemia, which is characterized by elevated triglycerides and low HDL cholesterol, elevated blood pressure, and glucose intolerance. Objective: The primary objective of this study is to evaluate the role of Calcarea carbonica 30C in reducing the risk factors associated with metabolic syndrome (MetS). The study aims to determine the clinical efficacy of Calcarea carbonica 30C in improving metabolic parameters such as fasting blood glucose, triglyceride levels, waist circumference, and body mass index in individuals diagnosed with metabolic syndrome. Methods: A case series comprising five patients diagnosed with metabolic syndrome was conducted over six months. These patients were selected based on predefined inclusion and exclusion criteria. Each patient received Calcarea carbonica 30C as a primary treatment for metabolic syndrome. Anthropometric measurements, blood pressure readings, and biochemical parameters were assessed at the baseline and again after the six-month treatment period to evaluate the impact of the homeopathic intervention. Results: The results demonstrated significant reductions in waist circumference, triglyceride levels, and blood pressure measurements among the patients who completed the treatment protocol. Additionally, fasting blood glucose levels and HDL cholesterol exhibited a trend of improvement, suggesting a potential role of Calcarea carbonica 30C in metabolic regulation. Conclusion: This case series suggests that Calcarea carbonica 30C may be beneficial in reducing metabolic syndrome risk factors and improving overall metabolic health.